SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028455
Filing Date
2023-08-14
Accepted
2023-08-14 16:10:55
Documents
78
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1047358
2 form10-q_001.jpg GRAPHIC 90888
3 ex31-1.htm EX-31.1 11713
4 ex31-2.htm EX-31.2 11994
5 ex32-1.htm EX-32.1 11079
  Complete submission text file 0001493152-23-028455.txt   6092910

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aztr-20230630.xsd EX-101.SCH 42189
7 XBRL CALCULATION FILE aztr-20230630_cal.xml EX-101.CAL 64882
8 XBRL DEFINITION FILE aztr-20230630_def.xml EX-101.DEF 218775
9 XBRL LABEL FILE aztr-20230630_lab.xml EX-101.LAB 356792
10 XBRL PRESENTATION FILE aztr-20230630_pre.xml EX-101.PRE 312135
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 859911
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra Inc (Filer) CIK: 0001701478 (see all company filings)

IRS No.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41705 | Film No.: 231170170
SIC: 2834 Pharmaceutical Preparations